Last night, by an 13-8 margin, the Senate Finance Committee approved the Chairman’s mark to S. 3 which would strike a provision from the Medicare Part D law that prohibits the Government from interfering in price negotiations between Medicare Part D plans and drug manufacturers and wholesalers. The Senate is scheduled to consider the bill next week. The House already has approved a similar bill, H.R. 4. The Administration has stated that the President will veto the bill if enacted by Congress.